Head-to-head · Cost-Efficiency Index
Bayan Health vs Zeuss
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Bayan Health
Cost-first shoppers who want a flat all-dose price across several routes and can commit to a two- or three-month protocol.
Visit Bayan HealthZeuss
Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription.
Visit ZeussThe verdict
Bayan Health takes it, leading the Cost-Efficiency Index 64 to 63. Bayan Health prices compounded semaglutide at $129 and tirzepatide at $149 a month, flat at every dose, and also sells oral drops, low-dose programs and orforglipron tablets — but ships two to three months at a time and bills for the whole protocol. Zeuss still earns a C — Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Bayan Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Bayan Health | Zeuss |
|---|---|---|
| Cost-Efficiency Index | 64/100 | 63/100 |
| Semaglutide / mo | $129.00/month billed monthly (standard injectable with vitamin B6; three months of medication ship at once) | $125/mo (starting dose, compounded) |
| Tirzepatide / mo | $149.00/month billed monthly (standard injectable with vitamin B6; same three-month protocol) | $175/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,548 | $1,500 |
| Tirzepatide / yr (modeled) | $1,788 | $2,100 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #184 | #186 |
Bayan Health
64/100Where the value is
- Among the lowest published flat rates for either molecule, with the medication, the physician consultation and expedited shipping inside the figure
- "Same Flat Price. No Matter the Dose." is stated on the product pages, so the cost does not climb as a provider titrates
- Sells six GLP-1 routes at published prices — standard and low-dose injections, oral drops for both molecules — plus orforglipron tablets at $269 a month
The tradeoffs
- Medication ships two or three months at a time and the terms say the payment obligation covers the entire protocol dispensed, so a monthly figure is not a monthly commitment
- Opting out requires 15 days' notice before the next protocol cycle, while the FAQ says you can cancel at any time
Zeuss
63/100Where the value is
- Genuinely no-subscription billing confirmed in its own FAQ ('no recurring charges or automatic refills') — patients pay per order, not a locked recurring plan
- LegitScript certified, with the badge and verification link displayed on the homepage
- States it 'partners exclusively with 503A and 503B state-licensed compounding pharmacies'
The tradeoffs
- Both $125 and $175 are 'starting at' prices with no disclosed dose (mg) or confirmation the price holds at higher/titrated doses
- No compounding pharmacy is named, only 'licensed partner pharmacy'
Regulatory note: the FDA issued a warning letter to Zeuss LLC dba Zeuss in February 2026. We still list and link to Zeuss; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.